Abstract
For centuries, lichens have been used in traditional medicine and their use persists to the present day in some parts of the world. Depsidones are one of the classes of secondary metabolites which are mostly produced in lichens. Lichen depsidones have been reported to possess many biological activities, such as antitumor and antimicrobial activities. In order to point out the pharmacological potential of this class of compounds, the present article reviews the structure and biological properties of the known lichen depsidones. The biosynthesis of depsidones and the relationship between their chemical structure and biological activity is also discussed.
Keywords: Biological activity, biosynthesis, depsidones, lichen, structure-activity relationship, Cyrenespora cassiicola, Garcinisidones, M14 cell line, Vicanicin, Lobaric acid
Mini-Reviews in Organic Chemistry
Title:Lichen Depsidones as Potential Novel Pharmacologically Active Compounds
Volume: 9 Issue: 2
Author(s): Gordana Stojanovic, Igor Stojanovic and Andrija Smelcerovic
Affiliation:
Keywords: Biological activity, biosynthesis, depsidones, lichen, structure-activity relationship, Cyrenespora cassiicola, Garcinisidones, M14 cell line, Vicanicin, Lobaric acid
Abstract: For centuries, lichens have been used in traditional medicine and their use persists to the present day in some parts of the world. Depsidones are one of the classes of secondary metabolites which are mostly produced in lichens. Lichen depsidones have been reported to possess many biological activities, such as antitumor and antimicrobial activities. In order to point out the pharmacological potential of this class of compounds, the present article reviews the structure and biological properties of the known lichen depsidones. The biosynthesis of depsidones and the relationship between their chemical structure and biological activity is also discussed.
Export Options
About this article
Cite this article as:
Stojanovic Gordana, Stojanovic Igor and Smelcerovic Andrija, Lichen Depsidones as Potential Novel Pharmacologically Active Compounds, Mini-Reviews in Organic Chemistry 2012; 9 (2) . https://dx.doi.org/10.2174/157019312800604689
DOI https://dx.doi.org/10.2174/157019312800604689 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Wnt Pathway: Emerging Anticancer Strategies
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Regulation of Arylamine N-Acetyltransferases
Current Drug Metabolism Revisiting Non-Cancer Drugs for Cancer Therapy
Current Topics in Medicinal Chemistry Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy
Current Drug Delivery The Disulfide Analogues of Isophosphoramide Mustard for Anticancer Therapy
Letters in Drug Design & Discovery Multidrug Resistance Through the Spectacle of P-Glycoprotein
Current Cancer Drug Targets Limiting Functional Deficiency Following Stroke: Exploiting Different Stem Cell Reservoirs
Current Neuropharmacology Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
Current Cancer Drug Targets Novel Purine Nucleoside Analogues for Hematological Malignancies
Recent Patents on Anti-Cancer Drug Discovery Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy
Current Gene Therapy Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Current Pharmaceutical Design Monoclonal Antibodies: New Therapeutic Agents for Autoimmune Hemolytic Anemia?
Endocrine, Metabolic & Immune Disorders - Drug Targets The Genetic Variants of IKZF1 Gene Linked with the Growing Risk of Childhood Acute Lymphoblastic Leukaemia
Current Molecular Medicine The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours
Current Pharmaceutical Design What Western Pharmacists Need to Know About Traditional Chinese Medicine; A Canadian Perspective
Current Traditional Medicine Cancer and Stem Cells
Current Cancer Therapy Reviews GSK3 Inhibitors and Disease
Mini-Reviews in Medicinal Chemistry Gene Therapy: Optimising DNA Delivery to the Nucleus
Current Drug Targets Drug Targeting Strategies in Cancer Treatment: An Overview
Mini-Reviews in Medicinal Chemistry